By Staff
Wednesday, September 28, 2022 12:24 AM
ST. LOUIS—
EyeCare Partners (ECP), a leading provider of clinically integrated eyecare, yesterday announced the launch of the EyeCare Partners Innovation Center with a mandate to improve the delivery and quality of eyecare and advance clinical eye health education. ECP described the Innovation Center as “an information and technology center of excellence” that will “unite the expertise of over 1,000 eyecare providers with data from E360+, EyeCare Partners’ proprietary data platform, to advance eyecare quality, research and education.
By Staff
Wednesday, September 28, 2022 12:15 AM
EMERYVILLE, Calif. & UBE, Japan—
Santen Inc., the U.S. subsidiary of Santen Pharmaceutical Co., Ltd. (Santen), and
UBE Corporation (UBE) announced on Monday that the U.S. Food and Drug Administration (FDA) has approved OMLONTI (omidenepag isopropyl ophthalmic solution) 0.002% eye drops for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension. The approval date was September 22. OMLONTI is developed jointly by Santen and UBE, according to the announcement.
By Staff
Tuesday, September 27, 2022 12:24 AM
SAN RAFAEL, Calif., and WASHINGTON, D.C.—
Guide Dogs for the Blind (GDB) and the
American Foundation for the Blind (AFB) have released the findings of The Role of Guide Dogs in 2022 and Beyond, a joint, two-year research study to examine the long-term outlook for guide dog use in the U.S. and Canada. Top findings for the first-of-its-kind study revealed a greatly expanded use of technology among travelers who are blind or visually impaired, and a shift to using rideshare services from public transit and walking.
By Staff
Tuesday, September 27, 2022 12:18 AM
SAN RAMON, Calif.—
CooperVision Specialty EyeCare has named Weiwen Chen as business manager, Asia-Pacific. In this newly-created role, she will lead the organization’s rapid growth and category expansion across the region.
By Staff
Monday, September 26, 2022 12:15 AM
SAN FRANCISCO, Calif.—
Travel Yukon, an arm of the Canadian province of Yukon’s department of tourism and culture, has collaborated with
EnChroma, a leading producer of glasses for colorblindness and low vision, to make the showstopping northern lights more accessible than ever before for the colorblind.
By Staff
Friday, September 23, 2022 12:24 AM
NEW YORK—U.S. consumers who require vision correction pay about $500 annually for eyeglasses, contact lenses, eye exams and insurance, compared with about $100 for those who have had LASIK surgery, according to a
new study. The study, conducted by a consortium of ophthalmologists and optometrists known as
MyVision.org, pointed out although glasses and contacts are game changers for people with “bad vision,” the annual costs of an eye exam, new eyeglass lenses, a year’s supply of contacts, and prescription sunglasses can add up to a considerable amount of money over the course of a person’s lifetime.
By Staff
Wednesday, September 21, 2022 12:21 AM
CHICAGO—
Prevent Blindness, the nation’s leading eye health and safety nonprofit organization, has declared Sept. 26 – Oct. 2, 2022, as the second annual Inflammatory Eye Disease (IED) Awareness Week.
By Staff
Tuesday, September 20, 2022 12:15 AM
MONROE, N.J.—The
Neuro-Optometric Rehabilitation Association, International, (NORA) recognized the following individuals last week at the NORA’s Annual Conference in Columbus, Ohio for their important contributions to NORA and the field of neuro-optometric rehabilitation. Derrick Tong, OD, FAAO, FCOVD, FNORA was recipient of the Advancement of Neuro-Optometric Rehabilitation Award in recognition of his contribution to advancing the field of Neuro-Optometric Rehabilitation. Dr. Tong has been practicing optometry since 1998 and received Fellowships from the American Academy of Optometry, the College of Optometrists in Vision Development, and the Neuro-Optometric Rehabilitation Association. For the last six years, he has served as chair of the NORA Fellowship Committee.
By Staff
Saturday, September 17, 2022 12:27 AM
VAUGHAN, Ontario—
Bausch + Lomb this week released a report of survey results from the company's first annual
Visionary Report which was designed to identify new key insights into the value Americans place on their eyesight, as well as the "blind spots" that may exist in the understanding and awareness of Age-related Macular Degeneration (AMD).
By Staff
Saturday, September 17, 2022 12:21 AM
COLUMBUS, Ga.—
Eye Health America (EHA) has acquired a stake in
West Georgia Eye Care Center, the largest multi-specialty ophthalmic practice in Columbus, Georgia. This is EHA’s second partnership in Georgia, and 22nd overall. Details of the transaction were not disclosed.
By Staff
Saturday, September 17, 2022 12:18 AM
DUBLIN—
Horizon Therapeutics plc is teaming up with World Sight Day organizers
IAPB to challenge five million people globally to pledge to have their vision checked before World Sight Day on Oct. 13. This year’s theme is #LoveYourEyes.
By Andrew Karp
Friday, September 16, 2022 8:30 AM
When Erik Ritchie took over in early 2021 as CEO of
EnChroma, he told me that he saw a huge opportunity to grow the company’s share of the market for color blindness eyewear, as well grow the market overall. “Just in the U.S. alone there are 13 million people who suffer from color blindness, and that market has traditionally been underserved,” he said in a
VMAIL interview. “One of my goals is to make sure we get the word out and raise awareness of not only the issue, but the solutions to that issue, and that we do that both in the U.S. and globally.”
By Staff
Friday, September 16, 2022 12:18 AM
ST. LOUIS—The
World Council of Optometry (WCO) and
Alcon have named three global experts as lead faculty for their new
dry eye disease education initiative. The worldwide evidence-based program is designed to raise optometrists’ understanding of dry eye etiology and prevalence, diagnosis and practical management. Professors Jennifer Craig, Lyndon Jones and James Wolffsohn will distill the growing amount of research and clinical evidence into accessible educational content. This will begin with a series of online events and content.